Clinical trial
A Non-interventional, Prospective, Cross-sectional Study of the Incidence of Pulmonary, Cardiovascular and Renal System Non-communicable Complications Associated With the Post-acute Phase of the Infection by Sars-Cov-2
NCT06608849 is registered in ClinicalTrials.gov with Hellenic Institute for the Study of Sepsis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Non-interventional, Prospective, Cross-sectional Study of the Incidence of Pulmonary, Cardiovascular and Renal System Non-communicable Complications Associated With the Post-acute Phase of the Infection by Sars-Cov-2
- Lead sponsor
- Hellenic Institute for the Study of Sepsis
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 10, 2024
- Completion date
- November 4, 2027
- Enrollment
- 345 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular complications, covid-19, pulmonary complications, renal complications